Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

Gastroenterology

Volumn 120, Issue 7, 2001, Pages 1763-1773

  Laurent Puig, Pierre ^a   Legoix, Patricia ^a   Bluteau, Olivier ^a   Belghiti, Jacques ^b   Franco, Dominique ^c   Binot, Frederic ^a   Monges, Geneviève ^d   Thomas, Gilles ^a   Bioulac Sage, Paulette ^e   Zucman Rossi, Jessica ^a  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b BEAUJON HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN P53;

ALLELE; ARTICLE; CANCER RISK; CHROMOSOME 13P; CHROMOSOME 17P; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME STRUCTURE; CONTROLLED STUDY; GENE MUTATION; HEPATITIS B VIRUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

EID: 0034995765     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.24798     Document Type: Article

References (45)

1. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
2. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma
3. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
4. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line
5. Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis
6. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis
7. Genetic alterations in liver carcinogenesis: Implications for new preventive and therapeutic strategies
8. Genetics of hepatocellular carcinoma
9. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
10. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
11. p53 gene mutation spectrum in hepatocellular carcinoma
12. Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas
13. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan
14. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
15. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
16. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
17. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
18. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
19. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity
20. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
21. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
22. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma
23. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma
24. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas
25. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
26. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma
27. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
28. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype
29. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization
30. Comprehensive allelotyping of human hepatocellular carcinoma
31. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
32. Analysis of genetic disorders of cancer of the rectum: Differences in relation to cancer of the colon
33. Semi-automated quantitative method for detecting the loss of heterozygosity at the long arm of chromosome 4 in hepatocellular carcinoma
34. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
35. Allelotype of colorectal carcinomas
36. Mutations of mitotic checkpoint genes in human cancers
37. p53 mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis
38. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA
39. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma
40. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice
41. Chromosome instability contributes to loss of heterozygosity in mice lacking p53
42. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
43. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma
44. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: Loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis
45. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma